Maze Therapeutics, Inc.

NasdaqGM:MAZE Stock Report

Market Cap: US$698.2m

Maze Therapeutics Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Jason Coloma

Chief executive officer

US$5.8m

Total compensation

CEO salary percentage9.0%
CEO tenure5.6yrs
CEO ownershipn/a
Management average tenure1.1yrs
Board average tenure4.3yrs

Recent management updates

No updates

Recent updates

CEO

Jason Coloma (48 yo)

5.6yrs

Tenure

US$5,835,244

Compensation

Dr. Jason V. Coloma, Ph D., M.P.H., MBA, serves as the Chief Executive Officer and Director of Maze Therapeutics, Inc. since July 2019 and served as its President, Chief Mazer and Chief Operating Officer u...

Leadership Team

NamePositionTenureCompensationOwnership
Jason Coloma
CEO & Director5.6yrsUS$5.84mno data
Harold Bernstein
President1.8yrsUS$2.40mno data
Courtney Phillips
General Counsel & Corporate Secretaryless than a yearUS$2.22mno data
Amy Bachrodt
Senior VP of Finance & CFO3.1yrsno datano data
Vipin Vijayakumar
Vice President of R&D Infrastructure & Operationsno datano datano data
Matt Krause
Senior Vice President of Human Resourcesno datano datano data
Atul Dandekar
Chief Strategy & Business Officer3.9yrsno datano data
Jillian Connell
Senior Vice President of Corporate Affairs & Capital Markets1.1yrsno datano data
Nazila Habibizad
Senior Vice President of Technical Operations & Supply Chain1.1yrsno datano data
Maarten Hoek
Senior Vice President of Research1.1yrsno datano data
Winston Tse
Senior Vice President of Drug Discovery1.1yrsno datano data
Andrew Good
VP & Corporate Controllerno datano datano data

1.1yrs

Average Tenure

52yo

Average Age

Experienced Management: MAZE's management team is not considered experienced ( 1.1 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Jason Coloma
CEO & Director5.6yrsUS$5.84mno data
Daniel Spiegelman
Independent Director4.3yrsUS$118.10kno data
Charles Homcy
Chairman of the Board6.7yrsUS$1.12mno data
Richard Scheller
Independent Director5.7yrsUS$178.22kno data
Jonathan Lim
Independent Director5.3yrsUS$98.10kno data
Alan Colowick
Independent Directorless than a yearno datano data
Catherine Sohn
Independent Director4.1yrsUS$113.43kno data
Jeffrey Tong
Independent Director6.3yrsno datano data
Neil Exter
Directorno datano datano data
Nancy Andrews
Independent Director4.1yrsUS$113.43kno data
Sekar Kathiresan
Independent Director2.8yrsUS$119.32kno data
James Brush
Independent Directorless than a yearno datano data

4.3yrs

Average Tenure

63.5yo

Average Age

Experienced Board: MAZE's board of directors are considered experienced (4.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/03 12:39
End of Day Share Price 2025/01/31 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Maze Therapeutics, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution